Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
27.7 /100
Rank 109 out of 131 Industries -
Advance/Decline
5/17
-
No. of Companies22
-
Avg. Market Cap4,048
-
Price to Earning Ratio19.26
-
Price to Earning Growth Ratio0.51
-
Price to Book Ratio11.46
-
Return on Equity35.45
-
Return on Capital Employed-
-
Return on Assets17.87
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-624.74 %
-
Net Profit Growth Qtr YoY %-123.02 %
-
Net Profit Growth Qtr QoQ %-461.39 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
349.9
|
19.0
|
L
 -2.6%
H
18.5
19.3
|
L
 -0.5%
H
18.2
21
|
L
 8.1%
H
17.6
21
|
L
 -11.2%
H
16.6
22.5
|
L
 -33.2%
H
16.6
38.3
|
L
 -71.8%
H
16.6
69.6
|
L
 -80.5%
H
16.6
107.9
|
L
 -69.6%
H
16.6
138.0
|
| Argen X SE (ADR) |
|
48,641.4
|
782.2
|
L
 -0.7%
H
778.1
792
|
L
 0.1%
H
775.0
840.7
|
L
 2.2%
H
754.8
852.3
|
L
 -3.6%
H
661.9
852.8
|
L
 25.6%
H
510.1
934.6
|
L
 93.5%
H
327.7
934.6
|
L
 196.6%
H
248.2
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.5
|
L
 -5.3%
H
0.5
0.6
|
L
 -27.0%
H
0.5
0.7
|
L
 -5.3%
H
0.5
1.1
|
L
 -34.9%
H
0.5
1.1
|
L
 -81.4%
H
0.5
6.2
|
L
 -72.2%
H
0.5
6.2
|
L
 -98.1%
H
0.5
99
|
L
 -98.5%
H
0.5
620
|
| Niagen Bioscience Inc |
|
352.6
|
4.2
|
L
 -0.5%
H
4.0
4.3
|
L
 -11.8%
H
4.0
5.1
|
L
 -6.7%
H
4.0
5.1
|
L
 -19.8%
H
4.0
5.8
|
L
 -50.7%
H
4.0
14.7
|
L
 206.6%
H
1.3
14.7
|
L
 -44.6%
H
1.2
14.7
|
L
 -10.1%
H
1.2
23.7
|
| Cronos Grp Inc |
|
955.7
|
2.5
|
L
 -1.2%
H
2.5
2.6
|
L
 -4.9%
H
2.5
2.7
|
L
 0.8%
H
2.5
3.3
|
L
 -3.8%
H
2.4
3.3
|
L
 37.3%
H
1.8
3.4
|
L
 26.4%
H
1.6
3.4
|
L
 -67.0%
H
1.6
9.4
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
5.7
|
2.9
|
L
 -10.1%
H
2.8
3.2
|
L
 -27.9%
H
2.8
4.6
|
L
 46.2%
H
1.7
7.9
|
L
 20.3%
H
1.7
7.9
|
L
 -80.4%
H
1.7
17.8
|
L
 -99.2%
H
1.7
1256.4
|
L
 -100.0%
H
1.7
33660
|
L
 -100.0%
H
1.7
12150000
|
| ZeroStack Corp |
|
13.4
|
5.5
|
L
 -1.1%
H
5.3
5.8
|
L
 -7.7%
H
4.9
6
|
L
 13.9%
H
4.8
7.6
|
L
 -40.9%
H
4.8
10.4
|
L
 -76.7%
H
4.8
47
|
L
 -96.5%
H
4.8
213.7
|
L
H
4.8
16731
|
L
H
4.8
16731
|
| IM Cannabis Corp |
|
1.5
|
0.2
|
L
 -7.7%
H
0.2
0.3
|
L
 -14.3%
H
0.2
0.3
|
L
 -31.4%
H
0.2
0.6
|
L
 -79.1%
H
0.2
1.2
|
L
 -85.5%
H
0.2
7.1
|
L
 -94.4%
H
0.2
8.6
|
L
 -99.9%
H
0.2
381
|
L
H
0.2
697.8
|
| Lifevantage Corp |
|
67.6
|
5.3
|
L
 6.4%
H
4.6
5.4
|
L
 5.7%
H
4.6
6.2
|
L
 32.2%
H
3.9
6.2
|
L
 6.2%
H
3.9
6.2
|
L
 -52.2%
H
3.9
15
|
L
 43.5%
H
3.7
27.4
|
L
 -28.5%
H
3.0
27.4
|
L
 -45.5%
H
2.9
27.4
|
| Mannatech Inc |
|
11.0
|
5.7
|
L
 22.1%
H
4.6
6.5
|
L
 30.1%
H
4.3
6.5
|
L
 -8.7%
H
4.3
8.5
|
L
 -22.9%
H
4.3
8.5
|
L
 -43%
H
4.3
12.5
|
L
 -56.2%
H
4.3
16.5
|
L
 -72.0%
H
4.3
49.1
|
L
 -70.1%
H
4.3
49.1
|
| Natural Alternatives Intl Inc |
|
16.5
|
2.7
|
L
 -2.6%
H
2.7
2.8
|
L
H
2.6
2.8
|
L
 -0.4%
H
2.6
2.9
|
L
 -16.8%
H
2.3
3.5
|
L
 -6.6%
H
2.3
5.0
|
L
 -65.8%
H
2.3
7.9
|
L
 -82.1%
H
2.3
19.9
|
L
 -76.5%
H
2.3
19.9
|
| Nature`s Sunshine Products Inc |
|
424.2
|
24.2
|
L
 -1.3%
H
22.7
25.5
|
L
 -10.8%
H
22.7
27.4
|
L
 -2.5%
H
22.7
28
|
L
 -8.0%
H
22.7
28.1
|
L
 82.9%
H
13.0
28.1
|
L
 125.2%
H
10.1
28.1
|
L
 17.3%
H
7.9
28.1
|
L
 159.1%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
1.3
|
1.2
|
L
 -1.6%
H
1.2
1.3
|
L
 6.9%
H
1.2
1.3
|
L
 -28.3%
H
1.0
2.1
|
L
 -91.9%
H
1.0
28.4
|
L
 -99.9%
H
1.0
1488
|
L
 -100.0%
H
1.0
5808
|
L
 -100.0%
H
1.0
44160
|
L
H
1.0
146400
|
| PharmaCyte Biotech Inc |
|
8.2
|
0.8
|
L
 -5%
H
0.7
0.8
|
L
 5.6%
H
0.7
0.8
|
L
 11.8%
H
0.6
0.8
|
L
 2.7%
H
0.6
0.8
|
L
 -30.9%
H
0.6
1.5
|
L
 -72.9%
H
0.6
3.2
|
L
 -96.7%
H
0.6
23.0
|
L
 -99.3%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
30.4
|
1.4
|
L
 -0.7%
H
1.3
1.4
|
L
 -6.2%
H
1.3
1.5
|
L
 10.5%
H
1.2
1.7
|
L
 -3.5%
H
0.9
1.7
|
L
 -61.5%
H
0.9
8.8
|
L
 -97.4%
H
0.1
63
|
L
 -99.9%
H
0.1
1560
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
28,092.3
|
141.8
|
L
 -0.5%
H
140.5
144.6
|
L
 -1.6%
H
139.4
151.4
|
L
 47.3%
H
94.6
155.7
|
L
 45.5%
H
91.5
155.7
|
L
 276.6%
H
34
155.7
|
L
 482.6%
H
15.5
155.7
|
L
 379.7%
H
14.1
155.7
|
L
H
14.1
155.7
|
| Upexi Inc |
|
92.3
|
1.4
|
L
 3.0%
H
1.3
1.4
|
L
 4.6%
H
1.3
1.5
|
L
 48.4%
H
1.0
1.5
|
L
 21.1%
H
0.5
1.5
|
L
 -88.0%
H
0.5
15.5
|
L
 -98.4%
H
0.5
91
|
L
H
0.5
187.4
|
L
H
0.5
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
2.0
|
0.6
|
L
 5.6%
H
0.5
0.6
|
L
 -23.0%
H
0.5
0.7
|
L
H
0.5
1.1
|
L
 -31.3%
H
0.5
1.1
|
L
 -79.6%
H
0.5
6.2
|
L
 -97.1%
H
0.5
46.9
|
L
 -99.8%
H
0.5
419
|
L
 -99.8%
H
0.5
6200
|
| FitLife Brands Inc |
|
89.7
|
9.6
|
L
 -0.1%
H
9.3
9.8
|
L
 3.2%
H
8.9
9.9
|
L
 -2.6%
H
8.7
10.8
|
L
 -37.8%
H
8.7
15.7
|
L
 -40.0%
H
8.7
21.0
|
L
 -42.3%
H
8.7
35.5
|
L
 -42.3%
H
8.7
35.5
|
L
 -42.3%
H
8.7
35.5
|
| Abivax (ADR) |
|
9,732.2
|
122.7
|
L
 -1.5%
H
121.2
126.7
|
L
 4.6%
H
114.9
129.2
|
L
 5.4%
H
106
129.2
|
L
 4.3%
H
100.2
133.4
|
L
 1754.1%
H
5.6
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
5.8
|
0.4
|
L
 -2.5%
H
0.4
0.5
|
L
 25.8%
H
0.3
0.5
|
L
 -41.8%
H
0.3
0.8
|
L
 -78.0%
H
0.3
1.8
|
L
 -79.1%
H
0.3
4
|
L
H
0.3
4.6
|
L
H
0.3
4.6
|
L
H
0.3
4.6
|
| iBio Inc |
|
61.8
|
1.7
|
L
 4.3%
H
1.6
1.8
|
L
 1.2%
H
1.5
1.8
|
L
 -19.0%
H
1.5
2.3
|
L
 -29.3%
H
1.4
3.1
|
L
 113.8%
H
0.6
3.8
|
L
 113.8%
H
0.6
3.8
|
L
 113.8%
H
0.6
3.8
|
L
 113.8%
H
0.6
3.8
|